China Universal Asset Management Company’s Ambrx Biopharma Inc AMAM Stock Holding History

China Universal Asset Management Company’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,303	Closed	-$104K	–	454
2023 Q4	$104K	Buy	+7,303	New	+$83K	0.02%	275

China Universal Asset Management Company's AMAM Position: Q1 2024 in Review

China Universal Asset Management Company sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 7,303 shares — an estimated $104K sold.

China Universal Asset Management Company first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $104K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

China Universal Asset Management Company reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
China Universal Asset Management Company sold 7,303 Ambrx Biopharma Inc shares in Q1 2024, an estimated $104K.
China Universal Asset Management Company first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
China Universal Asset Management Company's Ambrx Biopharma Inc position peaked at $104K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on China Universal Asset Management Company's 13F filing for Q1 2024, filed 29 Apr 2024.